本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

enVVeno Medical Corp.

0.3856
-0.0344-8.19%
成交量:62.73万
成交额:23.40万
市值:779.54万
市盈率:-0.36
高:0.3856
开:0.3700
低:0.3600
收:0.4200
52周最高:5.62
52周最低:0.3600
股本:2,021.62万
流通股本:1,908.56万
量比:3.53
换手率:3.29%
股息:- -
股息率:- -
每股收益(TTM):-1.0815
每股收益(LYR):-1.2728
净资产收益率:-57.19%
总资产收益率:-35.12%
市净率:0.26
市盈率(LYR):-0.30

数据加载中...

2022/10/27

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/11

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/11

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/05/11

[修订]季度报告

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
2022/04/29

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/04/18

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/28

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/19

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/03

重要事件披露

8-K/A [Amend] - Current report
2021/12/01

重要事件披露

8-K - Current report
2021/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/10/01

重要事件披露

8-K - Current report
2021/09/22

重要事件披露

8-K - Current report
2021/09/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/08

重要事件披露

8-K - Current report
2021/08/12

重要事件披露

8-K - Current report